Exact Sciences to Participate in June Investor Conferences
Exact Sciences, a key player in cancer screening and diagnostics, announced its participation in major investor conferences this June. The company will present at the William Blair 44th Annual Growth Stock Conference in Chicago on June 4, 2024, at 1:40 p.m. ET. They will also hold a fireside chat at the Jefferies Healthcare Conference in New York on June 5, 2024, at 11:00 a.m. ET, and another at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami on June 11, 2024, at 3:20 p.m. ET. Investors can join these events via webcast accessible through Exact Sciences' investor relations website.
- Participation in high-profile investor conferences enhances company visibility.
- Presentations and fireside chats provide platforms to update investors on business progress.
- Opportunities to attract new investors and strengthen relationships with existing shareholders.
- Potential to positively impact stock performance by addressing investor concerns and showcasing growth strategies.
- No new product or financial data announced, limiting immediate impact on stock valuation.
- Investor events require significant management time and resources, impacting operational focus.
- Potential for negative market reaction if investor expectations are not met during presentations.
-
William Blair 44th Annual Growth Stock Conference,
Chicago
Presentation on Tuesday, June 4, 2024 at 1:40 p.m. ET -
Jefferies Healthcare Conference,
New York
Fireside chat on Wednesday, June 5, 2024 at 11:00 a.m. ET -
Goldman Sachs 45th Annual Global Healthcare Conference,
Miami
Fireside chat on Tuesday, June 11, 2024 at 3:20 p.m. ET
The webcasts can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X (formerly known as Twitter) @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240528736572/en/
Erik Holznecht
Exact Sciences Corp.
investorrelations@exactsciences.com
608-800-6605
Source: Exact Sciences Corp.
FAQ
When is Exact Sciences presenting at the William Blair Annual Growth Stock Conference?
When is the Jefferies Healthcare Conference fireside chat with Exact Sciences?
When will Exact Sciences participate in the Goldman Sachs Annual Global Healthcare Conference?